U.S. Biosensors Market Size & Outlook, 2022-2030
U.S. biosensors market, 2018-2030 (US$M)
Related Markets
U.S. biosensors market highlights
- The U.S. biosensors market generated a revenue of USD 8,966.8 million in 2022 and is expected to reach USD 15,610.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.2% from 2023 to 2030.
- In terms of segment, electrochemical was the largest revenue generating technology in 2022.
- Optical is the most lucrative technology segment registering the fastest growth during the forecast period.
Biosensors market data book summary
| Market revenue in 2022 | USD 8,966.8 million |
| Market revenue in 2030 | USD 15,610.5 million |
| Growth rate | 7.2% (CAGR from 2022 to 2030) |
| Largest segment | Electrochemical |
| Fastest growing segment | Optical |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Thermal, Electrochemical, Piezoeletric, Optical |
| Key market players worldwide | Bio-Rad Laboratories Inc, Medtronic PLC, Abbott Laboratories, Biosensors, Pinnacle Financial Partners Inc, DuPont Nutrition & Biosciences, Johnson & Johnson, Koninklijke Philips NV, Nova Biomedical, Koch Industries, TDK Corp, Siemens AG |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.4% of the global biosensors market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. biosensors market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 3,390.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biosensors Market Scope
Biosensors Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. biosensors market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biosensors market will help companies and investors design strategic landscapes.
Electrochemical was the largest segment with a revenue share of 72.61% in 2022. Horizon Databook has segmented the U.S. biosensors market based on thermal, electrochemical, piezoeletric, optical covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held the largest market share in North America of over 40.00% in 2020.Furthermore, the recent outbreak of COVID-19 has positively impacted the biosensors market to a great extent. Many players operating in this market are introducing advanced products for detecting COVID-19.
For instance, SD Biosensor, INC. introduced STANDARD Q COVID-19 IgM/IgG Duo for the detection of SARS-CoV-2 in April 2020. The product is ideal for Point of Care (PoC) testing and allows rapid detection within 10 minutes. Therefore, such initiatives are anticipated to propel the demand for biosensors, thereby fueling the market growth over the forecast period.
Reasons to subscribe to U.S. biosensors market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. biosensors market databook
-
Our clientele includes a mix of biosensors market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biosensors market , including forecasts for subscribers. This country databook contains high-level insights into U.S. biosensors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. biosensors market size, by technology, 2018-2030 (US$M)
U.S. Biosensors Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
